{"nct_id":"NCT00619424","title":"A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors","status":"COMPLETED","status_verified_date":"2017-11","start_date":"2007-11-15","start_date_type":"ACTUAL","primary_completion_date":"2009-09-04","primary_completion_date_type":"ACTUAL","completion_date":"2009-09-04","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}